Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 231 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2784 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DOXY CAP 100MG | 100MG | CAPSULE | Resolved | 2024-03-15 | 2024-04-05 | 222414 |
| APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2024-03-15 | 2024-05-03 | 222481 |
| APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2024-03-27 | 2024-04-12 | 223540 |
| APO-LITHIUM CARBONATE | 150MG | CAPSULE | Actual shortage | 2024-04-19 | 2024-05-03 | 225802 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Actual shortage | 2024-04-26 | 2024-04-26 | 226318 |
| APO-LITHIUM CARBONATE | 300MG | CAPSULE | Actual shortage | 2024-05-03 | 2024-05-03 | 227079 |
| APO-RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2024-05-03 | 2024-05-17 | 227085 |
| APO-DOXY CAP 100MG | 100MG | CAPSULE | Actual shortage | 2024-05-10 | 2024-05-10 | 227728 |
| APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2020-08-14 | 2020-11-18 | 122276 |
| APO-FLUCONAZOLE-150 | 150MG | CAPSULE CAPSULE | Resolved | 2021-05-25 | 2021-09-20 | 139837 |
| APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2022-12-09 | 2023-01-31 | 177609 |
| APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2023-02-02 | 2023-02-09 | 183489 |
| APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2023-08-18 | 2023-09-12 | 202406 |
| APO-FLUCONAZOLE | Resolved | 2018-01-18 | 2018-05-04 | 36496 | ||
| APO-DIPYRIDAMOLE | Resolved | 2018-08-21 | 2018-09-17 | 58589 | ||
| APO-CEFPROZIL | Resolved | 2018-09-28 | 2019-06-12 | 62614 | ||
| APO-CEFPROZIL | Resolved | 2018-09-28 | 2019-05-24 | 62618 | ||
| APO-CANDESARTAN | Resolved | 2020-03-09 | 2020-05-04 | 108228 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
| APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
| APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
| ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 |